ProSomnus, MonitAir Partner to Integrate OSA Remote Monitoring
The collaboration integrates data from the ProSomnus RPMO₂ into MonitAir’s platform to support longitudinal tracking.
Tag: ProSomnus
All
Latest
All
Latest
John E. Remmers, MD, Sleep Physician Inventor, Dies
Sleep physician John E. Remmers, MD, an inventor of forward-thinking sleep medicine technologies and a prolific sleep researcher, died the morning of July 7.
All
Latest
How the Sleep Therapy Sector Is Responding to Philips Respironics’ Exit
Stakeholders predict what the years-long sales pause of Philips’ CPAPs will mean for sleep medicine.
![FDA Clears ProSomnus EVO [PH]](https://sleepreviewmag.com/wp-content/uploads/2022/11/ProSomnus-EVO-PH-Sleep-and-Snore-Device-150x150.png)
ProSomnus Reports Q1 Revenue Growth Amid Chapter 11 Restructuring
The company achieved a 28% increase in revenue, reaching $7.5 million, and maintained high on-time delivery rates.
Read More
ProSomnus Research on Oral Appliances for OSA to be Showcased
Accepted abstracts for the 2024 AADSM Annual Meeting explore enhanced health outcomes in OSA treatment with oral appliances and reduced staining in medical-grade class VI devices.
Read More
ProSomnus Oral Appliances to Be Highlighted in Research at 2024 AADSM Annual Meeting
Four independent scientific abstracts accepted for the meeting contain data utilizing ProSomnus oral appliances.
Read More
ProSomnus Files for Chapter 11 Bankruptcy to Secure Future Viability
ProSomnus has voluntarily filed for Chapter 11 bankruptcy, planning to cut its debt by 60% and inject $20 million into the company to support operations and new developments.
Read More
Oral Appliance Maker ProSomnus Reports Record Revenue for 2023
The company reported a 43% increase in annual revenue for 2023, driven in part by greater adoption of its oral appliance therapy for obstructive sleep apnea.
Read More
Seismic Shifts in the Sleep Therapy Landscape (Editor’s Message)
Tremblors from the Philips CPAP recall continue to shift the therapy landscape in sleep medicine.
Read More
Oximeter Embedded in Oral Appliance Shows Promise for Sleep Apnea Monitoring
A pilot study showed the technology can accurately, safely, and continuously monitor blood oxygen saturation, potentially providing ongoing assessment of the efficacy of oral appliance therapy.
Read More
FDA Reviews 510(k) Submission for ProSomnus Oral Appliance for Severe Sleep Apnea
The FDA is in the process of reviewing the company’s premarket notification for its ProSomnus EVO oral device for the treatment of patients with severe obstructive sleep apnea.
Read More
ProSomnus: ‘Well-Positioned’ to Aid in Wake of CPAP Device Withdrawal
Oral appliance therapy maker ProSomnus Inc announced its capability to support sleep apnea patients and sleep physicians affected by the discontinuation of certain CPAP devices.
Read More
UnitedHealthcare Mandates Oral Appliance Trial Before Sleep Apnea Surgery
UnitedHealthcare’s updated medical policy for obstructive and central sleep apnea establishes oral appliance therapy as a prerequisite therapy for surgical treatment in adult patients with moderate to severe OSA.
Read More
ProSomnus Oral Appliances Demonstrate Effectiveness in Treating OSA
A recent study reveals that precision oral appliance therapy devices, developed by ProSomnus Inc, are effective in treating patients with obstructive sleep apnea.
Read More
Oral Appliance Maker ProSomnus Reports Record Q3
ProSomnus Inc, a manufacturer of oral appliance therapy, reported record third-quarter revenue, marking its seventh consecutive quarter of revenue growth.
Read More
ProSomnus Sets Sights on Business Optimization with $10M Boost
ProSomnus raised $10 million in a convertible preferred equity offering to fuel growth and improve operations.
Read More
ProSomnus to Present New Data on Oral Appliance Efficacy and Safety
The data adds to the volume of independent evidence establishing precision oral devices as a leading treatment option for OSA, according to the company.
Read More
Preliminary Data Suggest Precision OAT Is Non-Inferior to CPAP
Updated clinical trial data indicate that the First Line Obstructive Sleep Apnea Treatment study, comparing precision oral appliance therapy and CPAP, is on track to achieve all endpoints, according to Prosomnus.
Read More